Skip to main navigation
  Menu

ASLAN Pharmaceuticals

  • Pipeline
  • Our Team
  • Investor Relations
  • News & Publications
  • Contact
EN
english中文

Investor Relations

Investor Relations

  • Investor Home
  • Corporate Information
  • Stock Information
  • News & Events
  • Financial Information
  • Shareholder Services

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Alerts sign up

Required fields denoted by an asterisk ().
Alert type

F-3

SEC Filing Details

Document Details

Form
F-3
Filing Date
Oct 31, 2019
Document Date
Oct 31, 2019
Form Description
Registration statement for certain foreign private issuers offered for certain transactions
Filing Group
Registration Statements
Company
ASLAN Pharmaceuticals
Issuer
ASLAN Pharmaceuticals Ltd

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

Shareholder Tools

  • Print Page

    Print Page

  • RSS Feeds

    RSS Feeds

  • E-mail Alerts

    E-mail Alerts

Company

  • Pipeline
  • Our Team
  • Investor Relations
  • News & Publications
  • Contact
  • Terms and Conditions

Footer Social Icons

Careers

For more information on employment opportunities at ASLAN, please contact us at careers@aslanpharma.com

Contact Us

Singapore Headquarters
3 Temasek Avenue, Level 18,
Singapore 039190
Tel: +65 6817 9598

contact@aslanpharma.com